Eliem Therapeutics Inc.

NASDAQ: ELYM · Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 10:00 PM

Eliem Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
87.23M 93.11M 43.59M 46.92M
Short-Term Investments
63.69M 13.69M 79.98M 89.56M
Long-Term Investments
n/a n/a n/a 24.92M
Other Long-Term Assets
61.83M 15K 128K 70K
Receivables
n/a 2.02M 6.49M n/a
Inventory
n/a n/a -6.49M 4.4M
Other Current Assets
3.95M 586K 3M 11.77M
Total Current Assets
154.87M 110.25M 134.39M 148.25M
Property-Plant & Equipment
490K 199K 471K n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
62.31M 214K 599K 24.99M
Total Assets
217.19M 110.47M 134.99M 173.24M
Account Payables
705K 66K 750K 1.4M
Deferred Revenue
n/a -66K n/a n/a
Short-Term Debt
157K 334K 300K n/a
Other Current Liabilities
4.07M -196K -300K n/a
Total Current Liabilities
4.93M 2.83M 6.1M 6.03M
Long-Term Debt
375K 15K 180K n/a
Other Long-Term Liabilities
n/a 7K -180K 7K
Total Long-Term Liabilities
375K 37K 180K 7K
Total Liabilities
5.31M 2.87M 6.28M 6.04M
Total Debt
532K 349K 480K n/a
Common Stock
7K 3K 3K 3K
Retained Earnings
-229.88M -155.98M -120.86M -75.62M
Comprehensive Income
23K -2K -358K -123K
Shareholders Equity
211.88M 107.6M 128.72M 167.2M
Total Investments
n/a 13.69M 79.98M 114.48M